DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,832,000 | -11.9% | 2,457,976 | +8.0% | 0.00% | 0.0% |
| Q3 2019 | $11,154,000 | -18.1% | 2,276,188 | +1.7% | 0.00% | -20.0% |
| Q2 2019 | $13,625,000 | +4.0% | 2,237,307 | -0.8% | 0.01% | 0.0% |
| Q1 2019 | $13,098,000 | -54.3% | 2,254,474 | +5.9% | 0.01% | -61.5% |
| Q4 2018 | $28,650,000 | -14.8% | 2,128,358 | +22.8% | 0.01% | 0.0% |
| Q3 2018 | $33,639,000 | +7.9% | 1,733,112 | +42.2% | 0.01% | +8.3% |
| Q2 2018 | $31,163,000 | +19.3% | 1,219,143 | -6.0% | 0.01% | +9.1% |
| Q1 2018 | $26,124,000 | -0.9% | 1,296,457 | -1.3% | 0.01% | 0.0% |
| Q4 2017 | $26,355,000 | +42.2% | 1,313,081 | +46.8% | 0.01% | +37.5% |
| Q3 2017 | $18,528,000 | +249.5% | 894,669 | +149.7% | 0.01% | +300.0% |
| Q2 2017 | $5,302,000 | +9.5% | 358,257 | +18.0% | 0.00% | 0.0% |
| Q1 2017 | $4,842,000 | +26.5% | 303,596 | -0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,827,000 | -53.2% | 303,696 | +4.1% | 0.00% | -50.0% |
| Q3 2016 | $8,172,000 | +534.5% | 291,794 | +693.2% | 0.00% | +300.0% |
| Q2 2016 | $1,288,000 | – | 36,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|